即將上市(暗盤交易時(shí)段:今日16:15-18:30)
| 公司名稱▼
/
代號▼ | 行業(yè) | 招股價(jià) | 每手股數(shù) | 入場費(fèi) | 招股截止日 | 暗盤日期▼ | 上市日期▲ |
|
同業(yè)比較 - 生物科技- 用品與服務(wù)
公司名稱/代號 | 現(xiàn)價(jià)2 | 今日升跌▼ | 十天升跌▼ | 市值▼ | 市盈率 (倍)▼ | 市帳率 (倍)▼ | 派息比率 (%)▼ | 股東權(quán)益 回報(bào)率(%)▼ | 經(jīng)營 利潤率(%)▼ | 總債項(xiàng)/ 股東權(quán)益(%)▼ | 選擇比較 |
雲(yún)頂新耀 01952.HK | 47.650 | +0.421% | +11.59% | 155.75億 | N/A | 3.59 | N/A | -2,557.00% | -14,422.00% | 1,349.00% | |
百濟(jì)神州 06160.HK | 156.100 | +0.775% | +7.14% | 2,402.87億 | N/A | 8.36 | N/A | -1,935.00% | -1,399.00% | 685.00% | |
藥明生物 02269.HK | 24.650 | -1.004% | +3.35% | 1,002.93億 | 28.19 | 2.28 | N/A | 803.00% | 2,673.00% | 1,181.00% | |
再鼎醫(yī)藥 09688.HK | 29.650 | +3.853% | +18.13% | 327.12億 | N/A | 4.97 | N/A | -3,057.00% | -6,387.00% | 1,825.00% | |
金斯瑞生物科技 01548.HK | 14.620 | +8.780% | +18.86% | 318.30億 | 1.35 | 0.93 | N/A | 6,854.00% | 28,270.00% | 395.00% | |
藥明康德 02359.HK | 70.750 | +0.071% | +4.58% | 273.86億 | 20.52 | 3.28 | 41.583% | 1,595.00% | 2,922.00% | 1,450.00% | |
亞盛醫(yī)藥-B 06855.HK | 55.400 | +0.819% | +9.59% | 193.04億 | N/A | 62.16 | N/A | -15,346.00% | -3,370.00% | 63,154.00% | |
康諾亞-B 02162.HK | 47.800 | +4.026% | +18.61% | 133.71億 | N/A | 5.08 | N/A | -2,082.00% | -11,327.00% | 3,044.00% | |
科濟(jì)藥業(yè)-B 02171.HK | 19.200 | +0.735% | -5.88% | 109.96億 | N/A | 9.77 | N/A | -7,553.00% | -200,906.00% | 1,575.00% | |
榮昌生物 09995.HK | 46.000 | -2.748% | -10.16% | 95.95億 | N/A | 11.85 | N/A | -7,393.00% | -8,162.00% | 13,445.00% | |
腦動極光-B 06681.HK | 6.870 | -0.579% | +0.73% | 86.99億 | N/A | N/A | N/A | -4,277.00% | -14,433.00% | N/A | |
樂普生物-B 02157.HK | 5.100 | +10.870% | +14.86% | 84.47億 | N/A | 11.67 | N/A | -5,853.00% | -10,462.00% | 11,954.00% | |
錦欣生殖 01951.HK | 2.950 | +2.787% | +7.66% | 80.97億 | 26.27 | 0.74 | N/A | 276.00% | 1,580.00% | 2,535.00% | |
來凱醫(yī)藥-B 02105.HK | 19.460 | +1.992% | +9.57% | 79.35億 | N/A | 9.27 | N/A | -3,160.00% | N/A | 1,296.00% | |
歌禮製藥-B 01672.HK | 7.650 | -0.907% | +16.26% | 73.72億 | N/A | 3.55 | N/A | -1,531.00% | -2,302,564.00% | 39.00% | |
和鉑醫(yī)藥-B 02142.HK | 7.960 | +0.887% | -9.65% | 65.99億 | 283.27 | 6.30 | N/A | 223.00% | 1,901.00% | 4,929.00% | |
和譽(yù)-B 02256.HK | 9.590 | +4.466% | +12.96% | 64.70億 | 201.90 | 3.13 | N/A | 145.00% | 1,580.00% | 124.00% | |
歐康維視生物-B 01477.HK | 7.660 | +1.862% | +6.24% | 62.34億 | N/A | 1.56 | N/A | -711.00% | -6,352.00% | 68.00% | |
基石藥業(yè)-B 02616.HK | 3.910 | -0.255% | +10.45% | 53.35億 | N/A | 12.98 | N/A | -2,507.00% | -1,867.00% | 9,783.00% | |
康希諾生物 06185.HK | 34.600 | +0.875% | +4.06% | 45.90億 | N/A | 1.64 | N/A | -772.00% | -3,689.00% | 4,101.00% | |
康龍化成 03759.HK | 15.400 | -2.284% | +10.32% | 45.32億 | 14.29 | 1.88 | 19.736% | 1,317.00% | 2,003.00% | 4,388.00% | |
|